MCM
KMTS

MAI Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

MAI Capital Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.4K Buy
772
+7
+0.9% +$165 ﹤0.01% 2932
2025
Q4 		$20.3K Hold
765
– – ﹤0.01% 2506
2025
Q3 		$18.2K Buy
+765
New +$13.7K ﹤0.01% 2445

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MAI Capital Management's KMTS Position: Q1 2026 in Review

MAI Capital Management increased its Kestra Medical Technologies (KMTS) stake by 0.92% in Q1 2026, buying an estimated $165 and bringing the position to 772 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

MAI Capital Management first reported a position in KMTS in Q3 2025 and has held it in 3 quarters since. The position peaked at $20.3K in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • MAI Capital Management held 772 shares of Kestra Medical Technologies worth $15.4K as of Q1 2026.
  • MAI Capital Management bought 7 Kestra Medical Technologies shares in Q1 2026, an estimated $165.
  • Kestra Medical Technologies made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #2932 holding.
  • MAI Capital Management first reported a position in Kestra Medical Technologies in Q3 2025 and has held it in 3 quarters since.
  • MAI Capital Management's Kestra Medical Technologies position peaked at $20.3K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.